Benitec Biopharma Inc.BNTC

$12.15+0.35 (+2.97%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$600M

Small-cap

+1296%

2016 — today

10-Year Price

-97%

2016 — today

52-Week Range

$10.06$16.52

Current $12.15· 32%

Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and BB-103, designed to combat chronic hepatitis B virus infection. Established in 1995, Benitec Biopharma's main operations are situated in Hayward, California.

Valuation in context

P/E ratio

-10.9

N/A

Not meaningful — company is unprofitable

P/B ratio

3.3

Below average

Below the 10-year average

FCF Yield

-3.4%

Historically high

Historically high relative to the last 10 years

Free · No credit card needed

Get alerted when BNTC is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.